NPR

Restrictions On Abortion Medication Deserve A Second Look, Says A Former FDA Head

The FDA heavily restricted mifepristone — a drug that ends early pregnancies — when it approved it 19 years ago. A former FDA commissioner asks whether the current restrictions should be revisited.
Mifepristone is a medication used to end early pregnancies and to relieve the symptoms of miscarriage. It's heavily restricted by the FDA.

Mifepristone is one of a regimen of two drugs approved by the Food and Drug Administration to end an early pregnancy. It's also prescribed to help reduce the severity of miscarriage symptoms. But it is heavily regulated in ways that can make it hard for women to obtain. Along with its approval in 2000, the FDA restricted its use because of safety concerns.

In a perspective article published this summer in the New England Journal of Medicine, former FDA Commissioner Dr. Jane Henney and co-author Dr. Helene Gayle argue that the agency should reevaluate whether such measures are still necessary and take into consideration recent studies that show mifepristone is both effective and safe.

Henney, who was FDA commissioner when. This program includes drugs such as antipsychotic medications and narcotics. Mifepristone is one of the most restricted of all drugs in the REMS program, Henney says.

You’re reading a preview, subscribe to read more.

More from NPR

NPR3 min readAmerican Government
A Michigan Grassroots Effort Is Raising Reparations, While The Government Lags
The year 2020 was a turning point for Lansing, Michigan resident Willye Bryan. Between the racial reckoning following the murder of George Floyd and the health disparities that hit the African American community during the pandemic, she knew it was t
NPR2 min readAmerican Government
Majorie Taylor Greene Is Planning A Vote Next Week To Oust Speaker Johnson
Rep. Marjorie Taylor Greene, R-Ga., says she will follow through on her threat to hold a vote to oust Speaker Mike Johnson sometime next week, despite signs that her effort will fail.
NPR2 min read
Walmart Says It Will Close Its 51 Health Centers And Virtual Care Service
The Arkansas-based company said that after managing the clinics it launched in 2019 and expanding its telehealth program, it concluded "there is not a sustainable business model for us to continue."

Related Books & Audiobooks